ISIN | LU1313771856 |
---|---|
Valor Number | |
Bloomberg Global ID | |
Fund Name | Candriam Sustainable Equity Europe C |
Fund Provider |
CANDRIAM
Serenity, Bloc - B, 19-21, route d'Arlon 8009 Strassen E-Mail: CH@Candriam.com Phone: + 352 2797-1 Web: https://www.candriam.com |
Fund Provider | CANDRIAM |
Representative in Switzerland |
CACEIS (Switzerland) SA Nyon Phone: +41 22 360 94 00 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The aim of the Sub-Fund is to enable shareholders to benefit from the growth of the European equity markets with an investment in equities selected by the portfolio management team on a discretionary basis and to outperform the benchmark. The selection is based on the stocks characteristics and growth prospects, as well as proprietary analysis of ESG criteria. |
Peculiarities |
Current Price * | 28.16 EUR | 03.04.2025 |
---|---|---|
Previous Price * | 28.77 EUR | 02.04.2025 |
52 Week High * | 30.14 EUR | 03.03.2025 |
52 Week Low * | 26.80 EUR | 20.11.2024 |
NAV * | 28.16 EUR | 03.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 913,534,815 | |
Unit/Share Assets *** | 135,188,942 | |
Trading Information SIX |
YTD Performance | +3.49% |
30.12.2024 - 03.04.2025
30.12.2024 03.04.2025 |
---|---|---|
YTD Performance (in CHF) | +4.34% |
30.12.2024 - 03.04.2025
30.12.2024 03.04.2025 |
1 month | -6.57% |
03.03.2025 - 03.04.2025
03.03.2025 03.04.2025 |
3 months | +3.42% |
03.01.2025 - 03.04.2025
03.01.2025 03.04.2025 |
6 months | -0.35% |
03.10.2024 - 03.04.2025
03.10.2024 03.04.2025 |
1 year | +1.22% |
03.04.2024 - 03.04.2025
03.04.2024 03.04.2025 |
2 years | +5.07% |
03.04.2023 - 03.04.2025
03.04.2023 03.04.2025 |
3 years | +4.03% |
04.04.2022 - 03.04.2025
04.04.2022 03.04.2025 |
5 years | +0.28% |
23.09.2021 - 03.04.2025
23.09.2021 03.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
KBC Groupe NV | 3.34% | |
---|---|---|
Nestle SA | 3.29% | |
FinecoBank SpA | 3.25% | |
ASML Holding NV | 3.12% | |
Roche Holding AG | 2.70% | |
AstraZeneca PLC | 2.63% | |
Kerry Group PLC Class A | 2.63% | |
Novartis AG Registered Shares | 2.56% | |
Novo Nordisk AS Class B | 2.52% | |
Siemens AG | 2.50% | |
Last data update | 28.02.2025 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.91% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |